Joint Scientific Consultation (JSC)

Joint Scientific Consultation (JSC) is a voluntary process that allows health technology developers to obtain early, coordinated advice from EU HTA bodies on their clinical development plans. This consultation aims to help developers design clinical studies that generate evidence suitable for both regulatory approval and a future joint clinical assessment. JSCs can be conducted in parallel with the European Medicine Agency’s scientific advice process, which helps to align the evidence requitements of both regulators and HTA bodies from an early stage. This proactive engagement is intended to streamline the development process and facilitate faster patient access to innovative therapies.